AstraZeneca

Timelines
Oxford COVID-19 vaccine generates immune response among young and old

26 Oct 2020

Oxford COVID-19 vaccine generates immune response among young and old

The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

22 Oct 2020

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

22 Oct 2020

AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

India to play crucial role in COVID-19 vaccine process

20 Oct 2020

India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

India may get COVID-19 vaccine by March 2021: SII official

17 Oct 2020

India may get COVID-19 vaccine by March 2021: SII official

India may get a vaccine for COVID-19 by March 2021, the Executive Director of the Serum Institute of India (SII) has said.

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

13 Oct 2020

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

COVAXIN to Oxford: Coronavirus vaccine updates for India

12 Oct 2020

COVAXIN to Oxford: Coronavirus vaccine updates for India

Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

04 Oct 2020

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.

Coronavirus vaccine roll-out expected within 3 months in UK: Report

03 Oct 2020

Coronavirus vaccine roll-out expected within 3 months in UK: Report

As the world awaits a vaccine against COVID-19, Oxford University's vaccine will reportedly be mass rolled-out within three months.

NewsBytes Briefing: Google launches new Pixel phones, and more

01 Oct 2020

NewsBytes Briefing: Google launches new Pixel phones, and more

Last night, Google held its Launch night event and showcased a bunch of new devices, including 5G-capable Pixel 5 and Pixel 4a, a new Chromecast dongle with mic-integrated remote, and redesigned, more powerful Nest Audio speakers.

Looking for COVID-19 vaccine update? Use this government portal

28 Sep 2020

Looking for COVID-19 vaccine update? Use this government portal

As the number of COVID-19 cases continues to surge across different parts of India, everyone has just one question on their mind: When will a vaccine be available?

UK planning "challenge trials" that deliberately expose volunteers to COVID-19

24 Sep 2020

UK planning "challenge trials" that deliberately expose volunteers to COVID-19

With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.

Johnson & Johnson's COVID-19 vaccine goes into final human trials

23 Sep 2020

Johnson & Johnson's COVID-19 vaccine goes into final human trials

In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.

COVID-19 vaccine: Serum Institute to start final trials this week

21 Sep 2020

COVID-19 vaccine: Serum Institute to start final trials this week

As India's COVID-19 cases continue to surge by nearly a lakh every passing day, scientists are racing to get a vaccine ready as soon as possible.

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

16 Sep 2020

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

14 Sep 2020

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

12 Sep 2020

AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.

Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

12 Sep 2020

Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

10 Sep 2020

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

10 Sep 2020

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

AstraZeneca halts coronavirus vaccine trial after volunteer falls ill

09 Sep 2020

AstraZeneca halts coronavirus vaccine trial after volunteer falls ill

Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.

Coronavirus: Australia leads race toward getting vaccinated, signs important deals

07 Sep 2020

Coronavirus: Australia leads race toward getting vaccinated, signs important deals

Australians might be the first ones to get protection from coronavirus, thanks to two deals that Prime Minister Scott Morrison has inked with those developing the vaccines.

#VaccineTracker: Early COVID-19 vaccine results expected by September 15

04 Sep 2020

#VaccineTracker: Early COVID-19 vaccine results expected by September 15

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

NewsBytes Briefing: Galaxy Z Fold2 price announced, and more

02 Sep 2020

NewsBytes Briefing: Galaxy Z Fold2 price announced, and more

Last night, Samsung held the second part of Galaxy Unpacked event and gave an in-depth look at its latest foldable phone - the Z Fold2.

Coronavirus vaccine tracker: When will one be ready?

27 Aug 2020

Coronavirus vaccine tracker: When will one be ready?

The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.

India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials

19 Aug 2020

India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials

In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.

NewsBytes Briefing: Reliance buys Netmeds, SpaceX's biggest fund-raise, and more

19 Aug 2020

NewsBytes Briefing: Reliance buys Netmeds, SpaceX's biggest fund-raise, and more

In the last few hours, renowned tech giants took major strides.

Australia secures 'promising' COVID-19 vaccine, will offer it for free

19 Aug 2020

Australia secures 'promising' COVID-19 vaccine, will offer it for free

In a bid to exit the COVID-19 pandemic for good, Australia has secured access to a "promising vaccine."

Indian government starts talks to procure COVID-19 vaccine: Details here

18 Aug 2020

Indian government starts talks to procure COVID-19 vaccine: Details here

Amid surging COVID-19 cases and questions over the peak for India, the government has started working towards procuring a vaccine.

India likely to have COVID-19 vaccine by December: Adar Poonawalla

11 Aug 2020

India likely to have COVID-19 vaccine by December: Adar Poonawalla

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

Serum Institute's COVID-19 vaccines will come at $3 per dose

07 Aug 2020

Serum Institute's COVID-19 vaccines will come at $3 per dose

In a major development, the Serum Institute of India has confirmed that the price of its foreign-licensed COVID-19 vaccines will be capped at $3 per dose in low-to-middle-income nations.

India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

06 Aug 2020

India's Serum Institute signs COVID-19 vaccine deal with America's Novavax

Serum Institute of India (SII) is set to source the COVID-19 vaccine developed by American biotech company Novavax.

Coronavirus: Who will be first in line for the vaccine?

04 Aug 2020

Coronavirus: Who will be first in line for the vaccine?

Amid global expedited efforts to develop a vaccine against the novel coronavirus, experts are debating who should be the first to be vaccinated.

SII gets nod for Oxford COVID vaccine phase 2/3 trials

03 Aug 2020

SII gets nod for Oxford COVID vaccine phase 2/3 trials

The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.

Coronavirus: How much would the vaccines cost?

30 Jul 2020

Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

How soon could there be a vaccine for COVID-19?

25 Jul 2020

How soon could there be a vaccine for COVID-19?

Since the coronavirus outbreak started late last year, researchers have been racing to develop a vaccine against the virus, SARS-CoV-2.

Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India

24 Jul 2020

Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India

In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.

As coronavirus pandemic surges, some vaccine makers expect to profit

22 Jul 2020

As coronavirus pandemic surges, some vaccine makers expect to profit

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap

22 Jul 2020

NewsBytes Briefing: Snap's revenue grows; Moderna's vaccine won't be cheap

The big story in the technology world is: Snap reported its earnings for Q2 2020 with notable gains - 9 million new users and 17% YoY growth in revenue.

Coronavirus vaccine will be available by 2021? Adar Poonawalla hopeful

22 Jul 2020

Coronavirus vaccine will be available by 2021? Adar Poonawalla hopeful

Adar Poonawalla, the chief of Serum Institute of India (SII), is hoping that vaccine to fight coronavirus will be available in India by the first quarter of 2021.